A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic

Stopped early · Phase 2/Phase 3

Conditions studied: Suicide, Attempted, Suicidal Ideation

In brief

The primary objective of this study is to assess the effectiveness of a digital intervention in reducing suicide attempts.

Key facts

Study ID

NCT05144685

Run by

Oui Therapeutics, Inc.

People needed

356

Starts

2022-04-07

Expected to finish

2024-06-14

Last updated by the study team

2025-06-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ages ≥18 years old
• Patients recently hospitalized.
• Owns a smartphone.
• Willing and able to complete enrollment procedures.
• Able to understand the nature of the study.
• Able and willing to provide at least two verifiable contacts.

You may not qualify if…

• Patients who have untreated psychosis or active psychosis
• Patients who appear to be impaired by the use of alcohol or other substance(s)
• Patients who sign, or have signed, an informed consent form to participate in any clinical research
• Patients who upon clinical examination are cognitively impaired
• Patients with a medical condition that may compromise, interfere, limit, effect or reduce the subject's ability to complete

Where it is running

• UCDDenver / Denver Health — Denver, Colorado, United States
• Yale — New Haven, Connecticut, United States
• Common Spirit — Omaha, Nebraska, United States
• Northwell Health — Glen Oaks, New York, United States
• University of Cincinnati — Cincinnati, Ohio, United States
• Harding Hospital — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.